{"id":609,"date":"2015-07-07T15:35:23","date_gmt":"2015-07-07T10:05:23","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=609"},"modified":"2023-06-14T12:35:26","modified_gmt":"2023-06-14T07:05:26","slug":"delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015","title":{"rendered":"DelveInsight launches Indication Active Pharmaceutical Ingredient (API) Reports"},"content":{"rendered":"<blockquote>\n<h4 style=\"text-align: center;\"><span style=\"color: #993366;\"><strong><em>DelveInsight expertise over 400+ Indication Active Pharmaceutical Ingredient (API) Reports<\/em><\/strong><\/span><\/h4>\n<\/blockquote>\n<p><img decoding=\"async\" class=\" size-medium wp-image-612 alignright\" src=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/indication-api-insights.png?w=236\" alt=\"Indication-API Insights\" width=\"236\" height=\"300\" srcset=\"https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/07\/indication-api-insights.png 421w, https:\/\/www.delveinsight.com\/blog\/wp-content\/uploads\/2015\/07\/indication-api-insights-236x300.png 236w\" sizes=\"(max-width: 236px) 100vw, 236px\" \/><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #000000;\"><a style=\"color: #000000;\" href=\"https:\/\/www.delveinsight.com\/\">DelveInsight<\/a>,<\/span> leading Market Research and Business Consulting firm has an expertise in providing business solutions to Pharma and biotech companies. DelveInsight has <span style=\"color: #ff6600;\"><strong>400+ Indication API reports<\/strong><\/span> on wide range of therapeutic area such as <strong>Oncology<\/strong>, <strong>Cardiovascular disease<\/strong>, and <strong>Autoimmune disorders<\/strong> and<strong> <span style=\"color: #000000;\">I<\/span>nfectious disease<\/strong>.<\/p>\n<p style=\"text-align: justify;\">DelveInsight\u2019s Indication API insight report provides global competitive and therapeutic assessment on marketed drugs, API manufacturers, patent expiration and exclusivity. The report gives clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries. These Reports gives complete information on marketed drugs along with <strong>Global API Manufacturers<\/strong> and <strong>regulatory filings across Europe, US, India and China<\/strong>. It gives information of global Market therapeutics scenario, regulatory information, marketing status and detail of product profiles for marketed products with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical description. The Report also provides <strong>Global drug sales forecast up to 2016<\/strong>.<\/p>\n<p style=\"text-align: justify;\">The Reports give opportunities to generic manufacturers and also helps API industry to track closest competitors and prioritizing new drug intermediates to add to the portfolio when drug goes off patent. The Indication API insight report helps to identify the strategic drivers and market opportunities.<\/p>\n<p style=\"text-align: justify;\">DelveInsight is offering the Report at a price of <strong>USD 1,250<\/strong> as a single user license, <strong>USD 2,500<\/strong> as a site license and <strong>USD 4,000<\/strong> as a Global\/Enterprise License.<\/p>\n<p>For more information on API insight Reports, email at <a href=\"mailto:info@delveInsight.com\">info@delveInsight.com<\/a><\/p>\n<h4><strong>About us<\/strong><\/h4>\n<p>DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver critical information to leading decision makers.<\/p>\n<p>We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight expertise over 400+ Indication Active Pharmaceutical Ingredient (API) Reports DelveInsight, leading Market Research and Business Consulting firm has an expertise in providing business solutions to Pharma and biotech companies. DelveInsight has 400+ Indication API reports on wide range of therapeutic area such as Oncology, Cardiovascular disease, and Autoimmune disorders and Infectious disease. DelveInsight\u2019s Indication [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":1,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[50,85,86,87,93,99,119,143,163,204,226,272,320,326,426,427,464,594],"industry":[17225],"therapeutic_areas":[17242,17227,17231,17228],"class_list":["post-609","post","type-post","status-publish","format-standard","hentry","category-articles","tag-400-indication-api-reports","tag-api-indication-reports","tag-api-intelligence","tag-api-manufacturers","tag-asmf","tag-autoimmune-disorders","tag-biotech","tag-cardiovascular-disease","tag-china","tag-delveinsight","tag-edmf","tag-global-drug-sales-forecast","tag-india","tag-infectious-disease","tag-off-patent","tag-oncology","tag-pharma","tag-usdmf","industry-pharmaceutical","therapeutic_areas-cardiovascular-diseases","therapeutic_areas-immunological-and-autoimmune-disorders","therapeutic_areas-infectious-diseases","therapeutic_areas-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Indication-based Active Pharmaceutical Ingredient (API) Reports<\/title>\n<meta name=\"description\" content=\"DelveInsight\u2019s Indication API insight report provides global competitive and therapeutic assessment on marketed drugs, API manufacturers, patent expiration.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Indication-based Active Pharmaceutical Ingredient (API) Reports\" \/>\n<meta property=\"og:description\" content=\"DelveInsight\u2019s Indication API insight report provides global competitive and therapeutic assessment on marketed drugs, API manufacturers, patent expiration.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-07-07T10:05:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-14T07:05:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/indication-api-insights.png?w=236\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Indication-based Active Pharmaceutical Ingredient (API) Reports","description":"DelveInsight\u2019s Indication API insight report provides global competitive and therapeutic assessment on marketed drugs, API manufacturers, patent expiration.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015","og_locale":"en_US","og_type":"article","og_title":"Indication-based Active Pharmaceutical Ingredient (API) Reports","og_description":"DelveInsight\u2019s Indication API insight report provides global competitive and therapeutic assessment on marketed drugs, API manufacturers, patent expiration.","og_url":"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2015-07-07T10:05:23+00:00","article_modified_time":"2023-06-14T07:05:26+00:00","og_image":[{"url":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/indication-api-insights.png?w=236","type":"","width":"","height":""}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015","url":"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015","name":"Indication-based Active Pharmaceutical Ingredient (API) Reports","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015#primaryimage"},"thumbnailUrl":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/indication-api-insights.png?w=236","datePublished":"2015-07-07T10:05:23+00:00","dateModified":"2023-06-14T07:05:26+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"DelveInsight\u2019s Indication API insight report provides global competitive and therapeutic assessment on marketed drugs, API manufacturers, patent expiration.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/delveinsights-indication-active-pharmaceutical-ingredient-api-reports-2015#primaryimage","url":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/indication-api-insights.png?w=236","contentUrl":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/indication-api-insights.png?w=236"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">400+ Indication API reports<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">API Indication reports<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">API Intelligence<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">API Manufacturers<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">ASMF<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Autoimmune disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Biotech<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Cardiovascular disease<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">China<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">DelveInsight<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">EDMF<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Global drug sales forecast<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">India<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Infectious Disease<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">off patent<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Oncology<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Pharma<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">USDMF<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">400+ Indication API reports<\/span>","<span class=\"advgb-post-tax-term\">API Indication reports<\/span>","<span class=\"advgb-post-tax-term\">API Intelligence<\/span>","<span class=\"advgb-post-tax-term\">API Manufacturers<\/span>","<span class=\"advgb-post-tax-term\">ASMF<\/span>","<span class=\"advgb-post-tax-term\">Autoimmune disorders<\/span>","<span class=\"advgb-post-tax-term\">Biotech<\/span>","<span class=\"advgb-post-tax-term\">Cardiovascular disease<\/span>","<span class=\"advgb-post-tax-term\">China<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight<\/span>","<span class=\"advgb-post-tax-term\">EDMF<\/span>","<span class=\"advgb-post-tax-term\">Global drug sales forecast<\/span>","<span class=\"advgb-post-tax-term\">India<\/span>","<span class=\"advgb-post-tax-term\">Infectious Disease<\/span>","<span class=\"advgb-post-tax-term\">off patent<\/span>","<span class=\"advgb-post-tax-term\">Oncology<\/span>","<span class=\"advgb-post-tax-term\">Pharma<\/span>","<span class=\"advgb-post-tax-term\">USDMF<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 11 years ago","modified":"Updated 3 years ago"},"absolute_dates":{"created":"Posted on Jul 7, 2015","modified":"Updated on Jun 14, 2023"},"absolute_dates_time":{"created":"Posted on Jul 7, 2015 3:35 pm","modified":"Updated on Jun 14, 2023 12:35 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=609"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/609\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=609"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=609"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}